Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Recurrence × Radiation × Clear all

Phase

Phase 2 2 Phase 1 2 Phase NA 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10 Prostatic Neoplasms 7 Head and Neck Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Carcinoma, Intraductal, Noninfiltrating 4 Brain Neoplasms 4 Lung Neoplasms 3 Glioblastoma 3 Endometrial Neoplasms 3 Uterine Cervical Neoplasms 2 Oropharyngeal Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Melanoma 2 Glioma 2 Carcinoma, Ductal, Breast 2 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Tonsillar Neoplasms 1 Symptomatic Osseous Bone Lesions From Any Malignancy 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Skin Diseases 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Retinoblastoma 1 Recurrence 1 Pelvic Inflammatory Disease 1

Interventions

Radiotherapy 10 fludarabine phosphate 6 Cyclophosphamide 6 Peripheral Blood Stem Cell Transplantation 5 Filgrastim 5 Cyclosporine 5 Whole-Body Irradiation 4 Surgical Procedures, Operative 4 Radiofrequency Ablation 4 Mycophenolic Acid 4 Melphalan 4 Drug Therapy 4 Cisplatin 4 Busulfan 4 Antilymphocyte Serum 4 Surveys and Questionnaires 3 Radiosurgery 3 Methotrexate 3 Injections 3 Cord Blood Stem Cell Transplantation 3 fludarabine 2 Vinblastine 2 Videotape Recording 2 Standard of Care 2 Procarbazine 2 Prednisolone 2 Practice Guidelines as Topic 2 Mastectomy 2 Lidocaine 2 Hepatectomy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00975520 2024-11-27

RTN2

Melanoma and Skin Cancer Trials Limited

Phase NA Completed

Melanoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡